USV Peptides Competitors

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

For over 35 years, we have been developing cutting-edge science and technology to empower biomedical research and personalized medicine. We combine excellence from more than 60 disciplines in natural sciences, engineering, and informatics to make a significant contribution to biomedical sciences. We encourage a creative working environment driven by pioneering spirit – to seek new horizons – boldly envisioning the future and turning it into reality. Today, more than 5,000 experts from over 75 countries contribute to our sustainable success.

Biosynth is a global partner in peptides with manufacturing facilities in Europe and United States, building on 40 years of experience in advancing and applying peptide expertise to facilitate customers in developing and producing peptides. Biosynth (Peptide Division), formerly vivitde and Pepscan - is showcasing its offering across the full range of peptide products and services. From custom peptide synthesis and library production, lead discovery and optimization, large scale peptide manufacture and GMP compliant NCEs, as well as class-leading neoantigen peptide programs. We are experienced in targeted nuclear medicine, both in diagnostic imaging and therapy as well as theranostics. Peptides play an important role in this field as they can specifically deliver both radioactive markers and therapies to a tumor. Biosynth offers a unique CLIPS™ phage display platform to discover highly constrained de novo peptides with enhanced affinity against your target of interest, selectivity, and proteolytic stability. With its custom antibody production and epitope mapping services, Biosynth also supports biotech companies in developing their antibody pipelines. The underlying protein mimicry platform delivers binding insights, even in cases where other technologies, such as linear mapping, fall short. Come and talk to the Biosynth team if you want to know how we can assist you in progressing your peptide project through (pre-) clinical development, application, and commercialization. With an unrivalled research product portfolio and end-to-end manufacturing services, we are science led and customer focused to solve problems and deliver key reagents across Complex Chemicals, Peptides and Key Biologics all from one trusted partner.